* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Swedish Plan
Survey
Document related concepts
Health system wikipedia , lookup
Influenza A virus subtype H5N1 wikipedia , lookup
Reproductive health wikipedia , lookup
Human mortality from H5N1 wikipedia , lookup
Health equity wikipedia , lookup
Rhetoric of health and medicine wikipedia , lookup
Transcript
Operational Pandemic Preparedness from a Tertiary Care Facility on the West Coast John Zarek, RPh System Clinical Manager Cardinal Health Pharmacy Management Swedish Medical Center, Seattle, WA 40th Annual ASHP Midyear Clinical Meeting and Exhibits December 6, 2005 Role of Pharmacy • Ad hoc member of Epidemiology Cmte. • Provide pharmaceutical care perspective on medication issues • Provide leadership role in assuring needed pharmaceutical products available within Swedish system • Provide link to pharmacist at Public Health Framing Questions • How should Swedish prepare knowing that there are limited therapy resources? • Does King County Public Health (KCPH) have plans to depot oseltamivir or how it should be prioritized? • Does KCPH have recommendations on how local institutions should be prepared? • How does KCPH view federal support? Framing Questions • How much oseltamivir is available in the wholesalers? • What will Roche do if there is stockpiling? • If there were a pandemic, how many patients should Swedish plan to treat? • How do we balance treatment of patients with prophylaxis of health care workers? Early Public Health Responses September, 2005 Oseltamivir: treatment over prophylaxis • Prioritization – Patients hospitalized with influenza – HCW & EMS workers with direct patient contact – Pandemic health responders, public safety & key government decision makers – Other high risk populations (undefined) Early Public Health Responses September, 2005 • Prophylaxis if adequate resources – – – – – Post-exposure in certain environments HCW in emergency departments & EMS workers ICUs and dialysis units Highest risk outpatients Other HCW with patient contact Antiviral Drug Distribution HHS Pandemic Influenza Plan, November, 2005 Priority Groups • Use in treatment in hospitals, clinics, & home health • Use in post-exposure prophylaxis (direct contacts of infected patients) • Use in prophylaxis (HCWs, public safety workers, essential service providers) Early Public Health Responses September, 2005 • Considering feasibility of acquiring a local stockpile of oseltamivir • Considering a hospital stockpile in accordance with HHS guidelines • KC healthcare coalition to address medical surge capacity & pandemic response • KCPH as possible broker to request and receive oseltamivir Decision to Purchase Oseltamivir • • • • • • • Treatment versus prophylaxis or both Contacting Roche Courses of therapy: 250, 500, 1000? Anticipated purchase cost: $15-66K Cardinal Health distribution center inventory Federal response capability: 72-96 hours? Integrating influenza treatment with stockpiling for avian pandemic (ability to handle 1st wave of infected patients) Clarifying with Roche about Oseltamivir Availability • • • • • • US supply chain Production plans Product issues Effectiveness in humans Benefits of preventative measures Perception of federal government response to limited supply North Carolina Guidelines on Stockpiling • Strongly discouraged personal stockpiling – No sustained human-to-human transmission in SE Asia of H5N1 virus – No H5N1 in US/North American poultry – Supplies of oseltamivir are limited and should be reserved for seasonal influenza – US pandemic plan: use in priority groups – Inappropriate use may lead to resistance » NC Dept HHS Memorandum October 19, 2005 Washington State Plan • Assumes limited resources • Maximizes response capabilities with established partnerships/existing assets • Part of Comprehensive Emergency Management Plan – – – – Initial phases (inter-pandemic period) Pandemic alert phase (Currently Level 3) Elevated pandemic alert stage Pandemic influenza phase KCPH Health Advisory October 17, 2005 • Arguments in favor of personal stockpile – Existing national stockpile is insufficient – Drug is widely available in private sector for seasonal flu therapy – Private sector supply might not contribute significantly to a pandemic response – No official recommendations by CDC or HHS against personal stockpiling KCPH Health Advisory October 17, 2005 • Arguments against a personal stockpile – Not recommended in draft national pandemic preparedness plan – May result in shortages for use in treatment & prevention of seasonal flu – No pandemic occurring currently – Effectiveness & optimal dose is unknown – Inappropriate use, when to start therapy? – Inequitable distribution Swedish Plan • Activate HEICS*: hospital emergency management plan • Adapt components of North Carolina guidelines & new HHS pandemic plan • Clarify tasks performed at various alert levels * Hospital Emergency Incident Command System Swedish Plan • Coordinate with KCPH and hospital coalition – application of altered standards of care if mass casualty • Coordinate with KCPH to prioritize oseltamivir utilization • Continuous respiratory etiquette, increased screening, decontamination, lock down Other Issues at Swedish • Communicating with hospital administration • Sharing the purchasing costs of drugs & personal protective equipment • Helping Physician Division with stockpiling issue • Establishing criteria for outpatient use of oseltamivir • Communicating with hospital information officers KCPH Health Advisory November 23, 2005 Screening & initial management of suspect human cases • Clinicians asked to take travel history on all radiographically confirmed pneumonia, acute respiratory distress syndrome or other respiratory illness for which an alternative diagnosis is not established • Compare travel history to list of countries with known avian influenza KCPH Health Advisory November 23, 2005 If patient meets clinical/epidemiological criteria for suspected case of H5N1 virus • Implement infection control precautions • Notify hospital Epidemiology & Public Health • Obtain clinical specimens for state testing • Evaluate alternative diagnoses • Decide on inpatient or outpatient care (coordinate with home health) • Initiate antiviral treatment within 48 hours of symptom onset Today’s Reality • Effective coordination & communication between pharmacy-Epidemiology-public healthinfectious disease • Continuously changing landscape • Tough choices on who gets treated in the hospital still to be made if mass casualty event • Uncertainty of HHS response • Reliance on coordinated plan with healthcare coalition • Reliance on Public Health critical